BioCentury
ARTICLE | Financial News

The Medicines Co. to sell follow-on

January 5, 2001 8:00 AM UTC

Fresh off of last month's FDA approval for its Angiomax bivalirudin direct thrombin inhibitor to treat unstable angina, MDCO filed to sell 4 million shares through J.P. Morgan; Robertson Stephens; CIB...